214 related articles for article (PubMed ID: 12769789)
1. Targeted inhibition of angiogenic factors in AIDS-related disorders.
Aoki Y; Tosato G
Curr Drug Targets Infect Disord; 2003 Jun; 3(2):115-28. PubMed ID: 12769789
[TBL] [Abstract][Full Text] [Related]
2. AIDS-related Kaposi's sarcoma cells rapidly internalize endostatin, which co-localizes to tropomysin microfilaments and inhibits cytokine-mediated migration and invasion.
Mallery SR; Morse MA; Wilson RF; Pei P; Ness GM; Bradburn JE; Renner RJ; Schuller DE; Robertson FM
J Cell Biochem; 2003 May; 89(1):133-43. PubMed ID: 12682914
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations.
Stebbing J; Wildfire A; Portsmouth S; Powles T; Thirlwell C; Hewitt P; Nelson M; Patterson S; Mandalia S; Gotch F; Gazzard BG; Bower M
Ann Oncol; 2003 Nov; 14(11):1660-6. PubMed ID: 14581275
[TBL] [Abstract][Full Text] [Related]
4. Cellular tropism and viral interleukin-6 expression distinguish human herpesvirus 8 involvement in Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease.
Staskus KA; Sun R; Miller G; Racz P; Jaslowski A; Metroka C; Brett-Smith H; Haase AT
J Virol; 1999 May; 73(5):4181-7. PubMed ID: 10196314
[TBL] [Abstract][Full Text] [Related]
5. gamma-Interferon produced by CD8+ T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with human immunodeficiency virus-1 Tat protein: an immune response to human herpesvirus-8 infection?
Fiorelli V; Gendelman R; Sirianni MC; Chang HK; Colombini S; Markham PD; Monini P; Sonnabend J; Pintus A; Gallo RC; Ensoli B
Blood; 1998 Feb; 91(3):956-67. PubMed ID: 9446657
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of vascular endothelial growth factor (VEGF) in Castleman's disease: proposed pathomechanism of vascular proliferation in the affected lymph node.
Nishi J; Maruyama I
Leuk Lymphoma; 2000 Jul; 38(3-4):387-94. PubMed ID: 10830746
[TBL] [Abstract][Full Text] [Related]
7. KSHV-Mediated Angiogenesis in Tumor Progression.
Purushothaman P; Uppal T; Sarkar R; Verma SC
Viruses; 2016 Jul; 8(7):. PubMed ID: 27447661
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells.
Nakamura S; Murakami-Mori K; Rao N; Weich HA; Rajeev B
J Immunol; 1997 May; 158(10):4992-5001. PubMed ID: 9144519
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory cytokines synergize with the HIV-1 Tat protein to promote angiogenesis and Kaposi's sarcoma via induction of basic fibroblast growth factor and the alpha v beta 3 integrin.
Barillari G; Sgadari C; Palladino C; Gendelman R; Caputo A; Morris CB; Nair BC; Markham P; Nel A; Stürzl M; Ensoli B
J Immunol; 1999 Aug; 163(4):1929-35. PubMed ID: 10438928
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's Sarcoma-Associated Herpesvirus: Epidemiology and Molecular Biology.
Li S; Bai L; Dong J; Sun R; Lan K
Adv Exp Med Biol; 2017; 1018():91-127. PubMed ID: 29052134
[TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma.
Cornali E; Zietz C; Benelli R; Weninger W; Masiello L; Breier G; Tschachler E; Albini A; Stürzl M
Am J Pathol; 1996 Dec; 149(6):1851-69. PubMed ID: 8952523
[TBL] [Abstract][Full Text] [Related]
12. Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: bidirectional translational science.
Dezube BJ; Sullivan R; Koon HB
J Cell Physiol; 2006 Dec; 209(3):659-62. PubMed ID: 17001705
[TBL] [Abstract][Full Text] [Related]
13. Transcriptional regulation of the interleukin-6 gene of human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus).
Deng H; Song MJ; Chu JT; Sun R
J Virol; 2002 Aug; 76(16):8252-64. PubMed ID: 12134031
[TBL] [Abstract][Full Text] [Related]
14. Synergy between Kaposi's sarcoma-associated herpesvirus (KSHV) vIL-6 and HIV-1 Nef protein in promotion of angiogenesis and oncogenesis: role of the AKT signaling pathway.
Zhu X; Guo Y; Yao S; Yan Q; Xue M; Hao T; Zhou F; Zhu J; Qin D; Lu C
Oncogene; 2014 Apr; 33(15):1986-96. PubMed ID: 23604117
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy.
Cannon M; Cesarman E
Semin Oncol; 2000 Aug; 27(4):409-19. PubMed ID: 10950367
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma cells of different etiologic origins respond to HIV-Tat through the Flk-1/KDR (VEGFR-2): relevance in AIDS-KS pathology.
Morini M; Benelli R; Giunciuglio D; Carlone S; Arena G; Noonan DM; Albini A
Biochem Biophys Res Commun; 2000 Jun; 273(1):267-71. PubMed ID: 10873597
[TBL] [Abstract][Full Text] [Related]
17. Pathogenesis and manifestations of human herpesvirus-8-associated disorders.
Aoki Y; Tosato G
Semin Hematol; 2003 Apr; 40(2):143-53. PubMed ID: 12704591
[TBL] [Abstract][Full Text] [Related]
18. Viral interleukin-6: role in Kaposi's sarcoma-associated herpesvirus: associated malignancies.
Sakakibara S; Tosato G
J Interferon Cytokine Res; 2011 Nov; 31(11):791-801. PubMed ID: 21767154
[TBL] [Abstract][Full Text] [Related]
19. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis, and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor. A novel strategy for the therapy of KS.
Ensoli B; Markham P; Kao V; Barillari G; Fiorelli V; Gendelman R; Raffeld M; Zon G; Gallo RC
J Clin Invest; 1994 Nov; 94(5):1736-46. PubMed ID: 7525646
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
